What was UNITEDHEALTH GROUP INC's revenue in Q2 2026?

UNITEDHEALTH GROUP INC reported revenue of $112.0B (+30.2% year-over-year) for Q2 2026.

What was UNITEDHEALTH GROUP INC's EPS in Q2 2026?

UNITEDHEALTH GROUP INC reported diluted EPS of $6.04 (+61.5% year-over-year) for Q2 2026.

UNITEDHEALTH GROUP INC (UNH) Earnings - Revenue, EPS & Net Income

8 quarters held2/5 transcripts analyzed2/40 figures attested

Connect your agent

PeriodRevenueYoYNet incomeEPS (dil.)Filed

Q2 2026$112.0B+30.2%$5.5B$6.04Aug 5, 2026

LATESTEarnings filing (8-K)10-QFiled Jul 16, 2026, 6:00 AM ET

Earnings call · Jul 16, 2026

	Q2 FY26	YoY	6M FY26
Revenue	$112.0B¹	+30.2%	$223.8B
Net income	$5.5B	+61.0%	$11.8B
Op income	$8.0B	+55.3%	$17.0B
EPS (dil.)	$6.04	+61.5%	–
EPS (basic)	–	–	–
Op margin	4.9%	+0.3pp
Net margin	4.9%	+1.8pp

[1] “Consolidated revenues for the second quarter 2026 were $112.0 billion” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

eps_diluted

$18.45—$18.95

eps_diluted

$19.50—$20.00

operating_income

25.4B—25.4B

net_income

No specific guidance provided

free_cash_flow

24.0B—24.0B

other

No specific guidance provided

operating_income

12.0B—12.0B

operating_income

2.3B—2.3B

operating_income

4.9B—4.9B

Special items & operational metrics

Operational metrics

Q2 2026

Days Claims Payable

+5.6% YoY

Prior year: 44.5

Days Sales Outstanding

17.7

-11.1% YoY

Prior year: 19.9

Medical Care Ratio

86.7

-3.0% YoY

Prior year: 89.4

Operating Cost Ratio

12.7

+3.3% YoY

Prior year: 12.3

Q1 2026$111.7B+2.0%$6.5B$6.90Apr 21, 2026

Earnings filing (8-K)10-QFiled Apr 21, 2026, 6:02 AM ET

Earnings call · Apr 21, 2026transcript View original prepared remarks Q&A

	Q1 FY26	YoY
Revenue	$111.7B	+2.0%
Net income	$6.5B	+0.1%
Op income	$9.0B	-1.4%
EPS (dil.)	$6.90	+0.7%
EPS (basic)	–	–
Op margin	8.0%	-0.3pp
Net margin	5.6%	-0.1pp

FY 2025$113.2B+12.3%$218.0M$0.01Jan 27, 2026

Earnings filing (8-K)10-KFiled Jan 27, 2026, 6:02 AM ET

Earnings call · Jan 27, 2026

	FY25	YoY
Revenue	$113.2B	+12.3%
Net income	$218.0M	-96.1%
Op income	$380.0M	-95.1%
EPS (dil.)	$0.01¹	-99.8%
EPS (basic)	–	–
Op margin	0.3%	-7.4pp
Net margin	0.2%	-5.3pp

[1] “Full year and fourth quarter 2025 net earnings were $13.23 and $0.01 per share.” view source

Q3 2025$113.2B+12.0%$2.3B$2.59Oct 28, 2025

Earnings filing (8-K)10-QFiled Oct 28, 2025, 6:02 AM ET

Earnings call · Oct 28, 2025transcript prepared remarks Q&A

	Q3 FY25	YoY	9M FY25
Revenue	$113.2B	+12.0%	$334.4B
Net income	$2.3B	-61.2%	$12.0B
Op income	$4.3B	-50.4%	$18.6B
EPS (dil.)	$2.59	-60.4%	$13.21
EPS (basic)	–	–	–
Op margin	3.8%	-4.8pp
Net margin	2.1%	-3.9pp

Q2 2025$111.6B+12.9%$3.4B$3.74Jul 29, 2025

Earnings filing (8-K)10-QFiled Jul 29, 2025, 6:04 AM ET

	Q2 FY25	YoY	6M FY25
Revenue	$111.6B	+12.9%	–
Net income	$3.4B	-19.2%	$13.3B
Op income	$5.2B	-34.6%	$21.6B
EPS (dil.)	$3.74	-17.6%	$14.65
EPS (basic)	–	–	–
Op margin	4.6%	-3.4pp
Net margin	3.1%	-1.2pp

Q1 2025$109.6B+9.8%$6.3B$6.85Apr 17, 2025

Earnings filing (8-K)10-QFiled Apr 17, 2025, 6:01 AM ET

	Q1 FY25	YoY
Revenue	$109.6B	+9.8%
Net income	$6.3B	–
Op income	$9.1B	+15.0%
EPS (dil.)	$6.85	–
EPS (basic)	–	–
Op margin	8.3%	+0.4pp
Net margin	5.7%	+7.1pp

Q4 2024$100.8B+6.8%$5.5B$5.98Jan 16, 2025

Earnings filing (8-K)10-KFiled Jan 16, 2025, 6:02 AM ET

	Q4 FY24	YoY	FY24
Revenue	$100.8B	+6.8%	$400.3B
Net income	$5.5B	+1.6%	$14.4B
Op income	$7.8B	+1.1%	$32.3B
EPS (dil.)	$5.98	+2.6%	$15.51
EPS (basic)	–	–	–
Op margin	7.7%	-0.4pp
Net margin	5.5%	-0.3pp

Q3 2024––––Oct 15, 2024

10-QFiled Oct 15, 2024, 6:03 AM ET

	Q3 FY24	YoY
Revenue	–	–
Net income	–	–
Op income	–	–
EPS (dil.)	–	–
EPS (basic)	–	–

Filing coverage

67 filings indexed · 77,825 XBRL facts

Filing	Date	Period	Sections	Tables
10-Q	2026-08-10	–	28	37
8-K	2026-07-16	Q2 2026	3	0
8-K	2026-06-05	–	1	0
10-Q	2026-05-05	–	28	29
DEF 14A	2026-04-21	–	36	0
8-K	2026-04-21	Q1 2026	3	0
8-K	2026-03-02	–	1	0
10-K	2026-03-02	–	52	62
8-K	2026-02-25	–	1	0
8-K	2026-01-27	Q4 2025	3	0

Showing the latest 10 of 67 — the full set is in the API.

Q2 FY26

YoY

6M FY26

Revenue

$112.0B¹

+30.2%

$223.8B

Net income

$5.5B

+61.0%

$11.8B

Op income

$8.0B

+55.3%

$17.0B

EPS (dil.)

$6.04

+61.5%

–

EPS (basic)

–

Op margin

4.9%

+0.3pp

Net margin

4.9%

+1.8pp

Q1 FY26

YoY

Revenue

$111.7B

+2.0%

Net income

$6.5B

+0.1%

Op income

$9.0B

-1.4%

EPS (dil.)

$6.90

+0.7%

EPS (basic)

–

Op margin

8.0%

-0.3pp

Net margin

5.6%

-0.1pp

FY25

YoY

Revenue

$113.2B

+12.3%

Net income

$218.0M

-96.1%

Op income

$380.0M

-95.1%

EPS (dil.)

$0.01¹

-99.8%

EPS (basic)

–

Op margin

0.3%

-7.4pp

Net margin

0.2%

-5.3pp

Q3 FY25

YoY

9M FY25

Revenue

$113.2B

+12.0%

$334.4B

Net income

$2.3B

-61.2%

$12.0B

Op income

$4.3B

-50.4%

$18.6B

EPS (dil.)

$2.59

-60.4%

$13.21

EPS (basic)

–

Op margin

3.8%

-4.8pp

Net margin

2.1%

-3.9pp

Q2 FY25

YoY

6M FY25

Revenue

$111.6B

+12.9%

–

Net income

$3.4B

-19.2%

$13.3B

Op income

$5.2B

-34.6%

$21.6B

EPS (dil.)

$3.74

-17.6%

$14.65

EPS (basic)

–

Op margin

4.6%

-3.4pp

Net margin

3.1%

-1.2pp

Q1 FY25

YoY

Revenue

$109.6B

+9.8%

Net income

$6.3B

–

Op income

$9.1B

+15.0%

EPS (dil.)

$6.85

–

EPS (basic)

–

Op margin

8.3%

+0.4pp

Net margin

5.7%

+7.1pp

Q4 FY24

YoY

FY24

Revenue

$100.8B

+6.8%

$400.3B

Net income

$5.5B

+1.6%

$14.4B

Op income

$7.8B

+1.1%

$32.3B

EPS (dil.)

$5.98

+2.6%

$15.51

EPS (basic)

–

Op margin

7.7%

-0.4pp

Net margin

5.5%

-0.3pp

Q3 FY24

YoY

Revenue

–

Net income

–

Op income

–

EPS (dil.)

–

EPS (basic)

–

Filing

Date

Period

Sections

Tables

10-Q

2026-08-10

–

8-K

2026-07-16

Q2 2026

8-K

2026-06-05

–

10-Q

2026-05-05

–

DEF 14A

2026-04-21

–

8-K

2026-04-21

Q1 2026

8-K

2026-03-02

–

10-K

2026-03-02

–

8-K

2026-02-25

–

8-K

2026-01-27

Q4 2025

Guidance & outlook

Management guidance

fy_current

Special items & operational metrics

Operational metrics

Filing coverage

Guidance & outlook

Management guidance

fy_current

Special items & operational metrics

Operational metrics

Filing coverage

Related Research

UnitedHealth's Medical Cost Crisis Is Worse Than Any Peer

Capital One's 60x P/E Is a $20.7B Provision Illusion — Normalized Earnings Tell a Different Story

Related Research

UnitedHealth's Medical Cost Crisis Is Worse Than Any Peer

Capital One's 60x P/E Is a $20.7B Provision Illusion — Normalized Earnings Tell a Different Story

UNITEDHEALTH GROUP INC (UNH) Earnings History

Guidance & outlook

Management guidance

fy_current

Special items & operational metrics

Operational metrics

Filing coverage

UNITEDHEALTH GROUP INC (UNH) Earnings History

Guidance & outlook

Management guidance

fy_current

Special items & operational metrics

Operational metrics

Filing coverage

Related Research

UnitedHealth's Medical Cost Crisis Is Worse Than Any Peer

Capital One's 60x P/E Is a $20.7B Provision Illusion — Normalized Earnings Tell a Different Story

Related Research

UnitedHealth's Medical Cost Crisis Is Worse Than Any Peer

Capital One's 60x P/E Is a $20.7B Provision Illusion — Normalized Earnings Tell a Different Story